Marathon Venture Partners

About The Fund

Marathon Venture Partners (MVP) is an early-stage venture capital firm established in 2016, operating out of Beijing, China. Specializing in digital health investments, MVP targets the growing market of transformative healthcare services catalyzed by digital innovation. The firm's investment interests span from medical devices, mobile healthcare, precision diagnosis, to medical insurance companies that exhibit core technology advancements and innovative business models. MVP aims to impact China's healthcare system by focusing on three foundational pillars: enhancing efficient access to medical services, implementing innovative payment models, and improving overall efficiency. Their investment strategy is informed by a belief in the burgeoning digital health sector in China, due to an aging population, limited access to quality services, and inefficient distribution channels. MVP aligns with the sweeping healthcare reforms in China by accelerating new device and drug reviews and supporting the restructuring of practice and distribution channels. Marathon Venture Partners is committed to the long-term support of their portfolio companies, navigating the challenges and tailwinds of early-stage growth. With both RMB and USD funds, MVP has invested in over 70 companies. The founding team manages over 3 billion RMB in investments and boasts a successful track record with numerous companies in their portfolio either being listed on stock exchanges or exiting through acquisitions. MVP's investment team is comprised of graduates from prestigious universities with robust industry experience and insights. The team offers varied expertise, with members having worked in direct investment, government, entrepreneurship, and the healthcare industry. Marathon Venture Partners emphasizes fostering new opportunities in crises and forging hopeful prospects amidst changes. Their investment approach also includes a digital health accelerator headed by experienced professionals. MVP has been recognized as a leading institution in healthcare investment by various industry accolades and team members have received individual honors for their investment acumen. With a comprehensive strategy and a deep understanding of the innovations shaping digital health in China, MVP seeks to harness the potential of early-stage ventures to address medical needs, extend life-cycle protection, and access quality services efficiently.